Anti-TNF therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells

先天免疫系统 肿瘤坏死因子α 免疫学 免疫系统 生物 受体 炎症 遗传学
作者
Shuyi Wang,Ruoxi Xiao,Yibo Chen,Yishan Ye,Tianzhen He,Yang Yang,Xin Chen,Chon‐Kit Chou
出处
期刊:Journal of Leukocyte Biology [Oxford University Press]
标识
DOI:10.1093/jleuko/qiaf026
摘要

Abstract Systemic autoinflammatory diseases (SAIDs) are rare conditions resulting from innate immune system dysregulation, culminating in repetitive bouts of systemic inflammation without the presence of external or self-antigens. Most SAIDs are associated with mutations in genes affecting the innate immune response. Tumor necrosis factor (TNF) is a central player in the pathogenesis of numerous chronic inflammatory disorders, and anti-TNF therapy is widely used in the clinical management of SAIDs. TNF inhibitors block the interaction of TNF with its two receptors, TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2). These inhibitors primarily target soluble TNF (sTNF), which mainly binds to TNFR1, exerting anti-inflammatory effects. Interestingly, TNF inhibitors also affect transmembrane TNF (tmTNF), which engages TNFR2 to initiate reverse signaling. This reverse signaling can activate innate immune cells, prevent apoptosis, or paradoxically inhibit the production of pro-inflammatory cytokines. TNF inhibitors also promote the release of soluble TNFR2 (sTNFR2), which neutralizes circulating TNF. Some agents targeting TNFR2 can even act as agonists, triggering reverse signaling by binding to tmTNF. While effective, prolonged use of TNF inhibitors may cause significant side effects due to the widespread expression and pleiotropic functions of TNF receptors. More thoroughly understanding of the mechanisms underlying the action of TNF inhibitors is required to develop more effective and safer treatment for SAIDs. This article reviews current studies on the role of the innate immune system in SAID pathogenesis, the impact of anti-TNF therapy on innate immune cells, and perspectives on developing improved agents targeting TNF or its receptors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SciGPT应助科研通管家采纳,获得10
刚刚
SYLH应助科研通管家采纳,获得10
刚刚
Owen应助科研通管家采纳,获得10
刚刚
SYLH应助科研通管家采纳,获得30
刚刚
在水一方应助马马采纳,获得10
刚刚
FashionBoy应助科研通管家采纳,获得10
1秒前
烟花应助末末采纳,获得10
1秒前
领导范儿应助科研通管家采纳,获得10
1秒前
1秒前
SYLH应助科研通管家采纳,获得30
1秒前
小二郎应助科研通管家采纳,获得10
1秒前
CodeCraft应助科研通管家采纳,获得10
1秒前
FashionBoy应助科研通管家采纳,获得10
1秒前
静静应助科研通管家采纳,获得10
1秒前
1秒前
orixero应助科研通管家采纳,获得10
1秒前
彭于晏应助科研通管家采纳,获得10
1秒前
2秒前
刘光正发布了新的文献求助10
3秒前
无奈的醉薇完成签到,获得积分10
3秒前
wish完成签到,获得积分10
5秒前
王加通完成签到,获得积分10
5秒前
6秒前
111发布了新的文献求助10
6秒前
宇宙凛发布了新的文献求助10
6秒前
燃尔完成签到 ,获得积分10
7秒前
打打应助哈哈哈采纳,获得10
7秒前
大白发布了新的文献求助10
7秒前
星期八发布了新的文献求助10
8秒前
yuyan发布了新的文献求助10
9秒前
10秒前
yalan发布了新的文献求助10
11秒前
隐形曼青应助澡雪采纳,获得10
11秒前
12秒前
Ava应助美满的砖头采纳,获得10
13秒前
13秒前
13秒前
bkagyin应助曾哥帅采纳,获得10
14秒前
14秒前
teng发布了新的文献求助20
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975816
求助须知:如何正确求助?哪些是违规求助? 3520159
关于积分的说明 11201128
捐赠科研通 3256541
什么是DOI,文献DOI怎么找? 1798347
邀请新用户注册赠送积分活动 877539
科研通“疑难数据库(出版商)”最低求助积分说明 806426